Savara to Present at the Barclays 26th Annual Global Healthcare Conference

Mittwoch, 06.03.2024 21:05 von

</head><p> <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.savarapharma.com%2F&esheet=53905898&newsitemid=20240306913347&lan=en-US&anchor=Savara+Inc.&index=1&md5=8db72ec90e229227c257d7ba3e661f14" shape="rect">Savara Inc.</a> (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on March 14, 2024 at 5:00am PT/8:00am ET. A live webcast of the fireside chat will be available on Savara’s website at <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.savarapharma.com%2Finvestors%2Fevents-presentations%2F&esheet=53905898&newsitemid=20240306913347&lan=en-US&anchor=www.savarapharma.com%2Finvestors%2Fevents-presentations%2F&index=2&md5=97f5397a36ee16a6706c37bb925a85ac" shape="rect">www.savarapharma.com/investors/events-presentations/</a> and will be archived for 90 days. </p><p> <b>About Savara <br /></b>Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow<sup>® </sup>Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization. More information can be found at <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.savarapharma.com&esheet=53905898&newsitemid=20240306913347&lan=en-US&anchor=www.savarapharma.com&index=3&md5=20a635ba5ac61f6b520238fa4a2cfcb4" shape="rect">www.savarapharma.com</a>. (X, formerly known as Twitter: <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftwitter.com%2FSavaraPharma%3Flang%3Den&esheet=53905898&newsitemid=20240306913347&lan=en-US&anchor=%40SavaraPharma&index=4&md5=1ca6452bf2a7208673c03eef9930ec7a" shape="rect">@SavaraPharma</a>, LinkedIn: <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fsavara-pharmaceuticals%2F&esheet=53905898&newsitemid=20240306913347&lan=en-US&anchor=www.linkedin.com%2Fcompany%2Fsavara-pharmaceuticals%2F&index=5&md5=d4f5ea6afac37c3243d7e3ed2bdbf21f" shape="rect">www.linkedin.com/company/savara-pharmaceuticals/</a>). </p><p><div class="fixed-container"><amp-img class="contain center" layout="fill" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20240306913347r1&sid=ariv2&distro=ftp" ></div><span class="bwct31415" /></p><p id="mmgallerylink"><span id="mmgallerylink-phrase">View source version on businesswire.com: </span><span id="mmgallerylink-link"><a href="https://www.businesswire.com/news/home/20240306913347/en/" rel="nofollow">https://www.businesswire.com/news/home/20240306913347/en/</a></span></p></html> <div class="abstand"></div> <div class="arheadgl"> <h3 class="arhead">Weitere Themen</h3> </div> <div id="more_news"> <div> <a href="/news/roundup-aktien-new-york-schluss-dow-fllt-unter-40-000-11251725"> <div class="thumbnail_1 thumbnail"> <div class="position_fix"> <div class="overlay"> <span class="date"> 20.05.24 </span> </div> </div> </div> ROUNDUP/Aktien New York Schluss: Dow fällt unter 40 000 Punkte - Nasdaq legt zu </a> </div> <div> <a href="/news/aktien-new-york-schluss-dow-fllt-unter-40-000-punkte-11251711"> <div class="thumbnail_2 thumbnail"> <div class="position_fix"> <div class="overlay"> <span class="date"> 20.05.24 </span> </div> </div> </div> Aktien New York Schluss: Dow fällt unter 40 000 Punkte - Nasdaq legt zu </a> </div> <div> <a href="/news/aktien-new-york-dow-fllt-unter-40-000-punkte-nasdaq-mit-11251621"> <div class="thumbnail_3 thumbnail"> <div class="position_fix"> <div class="overlay"> <span class="date"> 20.05.24 </span> </div> </div> </div> Aktien New York: Dow fällt unter 40 000 Punkte - Nasdaq mit Gewinnen </a> </div> <div> <a href="/news/roundup-aktien-frankfurt-schluss-dax-gelingt-am-feiertag-11251554"> <div class="thumbnail_4 thumbnail"> <div class="position_fix"> <div class="overlay"> <span class="date"> 20.05.24 </span> </div> </div> </div> ROUNDUP/Aktien Frankfurt Schluss: Dax gelingt am Feiertag guter Wochenauftakt </a> </div> <div> <a href="/news/aktien-frankfurt-schluss-dax-gelingt-am-feiertag-positiver-11251511"> <div class="thumbnail_5 thumbnail"> <div class="position_fix"> <div class="overlay"> <span class="date"> 20.05.24 </span> </div> </div> </div> Aktien Frankfurt Schluss: Dax gelingt am Feiertag positiver Wochenauftakt </a> </div> <div> <a href="/news/roundup-aktien-new-york-dow-tritt-bei-40-000-punkten-auf-11251410"> <div class="thumbnail_6 thumbnail"> <div class="position_fix"> <div class="overlay"> <span class="date"> 20.05.24 </span> </div> </div> </div> ROUNDUP/Aktien New York: Dow tritt bei 40 000 Punkten auf der Stelle </a> </div> </div> <div class="buttonNew"> <div> <a href="/news/"> Weitere Themen <span>»</span> </a> </div> </div> </div> </div> <amp-analytics type="gtag" data-credentials="include"> <script type="application/json"> { "vars" : { "gtag_id": "UA-154038-1", "config" : { "UA-154038-1": { "groups": "default" } } } } </script> </amp-analytics> </body> </html>